Supplemental High Flow Oxygen to Reduce Infections in Obese Gynecological Cancer Patients
Supplemental Administration of High Flow Oxygen to Enhance Postoperative Recovery and Reduce Infections in Obese Gynecological Cancer Patients
National and Kapodistrian University of Athens
400 participants
Jan 10, 2025
INTERVENTIONAL
Conditions
Summary
The incidence of surgical-site infection (SSI) and complications related to wound healing reaches 10-20% of gynecological cancer patients. Each complication may dramatically prolong the hospitalization period and increase the economic burden of hospital care. Appropriate wound care and tissue oxygenation are of special importance for wound healing. Assuming adequate perfusion, the easiest, safest, and most effective way to improve tissue oxygenation is to increase the fraction of inspired oxygen. However, there is considerable controversy as to whether supplemental oxygen actually reduces SSI and healing-related complications as to date, there is absence of relevant data.
Eligibility
Inclusion Criteria3
- Obese (BMI>30kg/m2) gynecological cancer patients
- Optimized preoperative CBC values (hemoglobin >11g/dl, WBC 4.000-11.000 X 109/L, platelets 150,000 to 400,000 X 109/L)
- In the case of neoadjuvant therapy an interval longer than three weeks between the last cycle and the operation
Exclusion Criteria3
- Active immunosuppresion
- Preexisting infection of the abdominal wall
- Preexisting sepsis
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
In this grou participants will receive supplemental oxygen in the form of a Venturi mask upon low oxygen saturation in oximetry (SaO2\<95%) and a nasal oxygen mask in all other cases during the first 2 postoperative days
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06780813